Di Lorenzo, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 1.326
SA - Sud America 922
NA - Nord America 381
EU - Europa 220
AF - Africa 73
OC - Oceania 4
Totale 2.926
Nazione #
BR - Brasile 782
SG - Singapore 668
US - Stati Uniti d'America 276
CN - Cina 186
VN - Vietnam 158
HK - Hong Kong 108
IT - Italia 88
MX - Messico 56
AR - Argentina 45
BD - Bangladesh 31
GB - Regno Unito 26
IN - India 25
EC - Ecuador 24
IQ - Iraq 23
CA - Canada 21
ID - Indonesia 21
NL - Olanda 19
SA - Arabia Saudita 18
TR - Turchia 17
VE - Venezuela 17
ZA - Sudafrica 17
PY - Paraguay 15
CO - Colombia 14
DE - Germania 14
UZ - Uzbekistan 14
RU - Federazione Russa 13
UA - Ucraina 13
EG - Egitto 12
MA - Marocco 12
PK - Pakistan 9
JO - Giordania 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
BO - Bolivia 6
FR - Francia 6
TN - Tunisia 6
CH - Svizzera 5
CL - Cile 5
ES - Italia 5
ET - Etiopia 5
JM - Giamaica 5
LB - Libano 5
PE - Perù 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
KZ - Kazakistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
AU - Australia 3
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KG - Kirghizistan 3
NP - Nepal 3
PS - Palestinian Territory 3
BH - Bahrain 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
GR - Grecia 2
HN - Honduras 2
LI - Liechtenstein 2
PA - Panama 2
RS - Serbia 2
AT - Austria 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GF - Guiana Francese 1
GN - Guinea 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
SV - El Salvador 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 2.926
Città #
Singapore 429
Beijing 97
Hong Kong 92
Ho Chi Minh City 68
São Paulo 50
Mexico City 41
Rome 28
Hanoi 27
Rio de Janeiro 18
Brasília 16
Belo Horizonte 14
Naples 14
Haiphong 13
Tashkent 13
Campinas 12
Chicago 12
Salvador 12
Curitiba 11
Baghdad 9
Goiânia 9
Porto Alegre 9
Amman 8
Dhaka 8
Santo André 8
Boardman 7
Guayaquil 7
Johannesburg 7
Milan 7
Montevideo 7
New York 7
Quito 7
Ribeirão Preto 7
Contagem 6
Fortaleza 6
Jeddah 6
João Pessoa 6
Sorocaba 6
Uberlândia 6
Ashburn 5
Belford Roxo 5
Cairo 5
Cape Town 5
Casablanca 5
Cleveland 5
Guarulhos 5
Istanbul 5
Lahore 5
Manaus 5
Mauá 5
Nairobi 5
Riyadh 5
Asunción 4
Barquisimeto 4
Belém 4
Bragança Paulista 4
Buenos Aires 4
Charlotte 4
Da Nang 4
Dubai 4
Franca 4
Joinville 4
Juiz de Fora 4
Jundiaí 4
La Paz 4
Maricá 4
Nepean 4
Philadelphia 4
Praia Grande 4
Sete Lagoas 4
Taubaté 4
Toronto 4
Vancouver 4
Addis Ababa 3
Anaheim 3
Ankara 3
Atlanta 3
Baku 3
Balneário Camboriú 3
Baltimore 3
Biên Hòa 3
Blumenau 3
Bridgetown 3
Caracas 3
Caxias do Sul 3
Colíder 3
Córdoba 3
Dallas 3
Dammam 3
Delhi 3
Divinópolis 3
Erbil 3
Francisco Morato 3
Governador Valadares 3
Ha Long 3
Indianapolis 3
Irecê 3
Itanhaém 3
Itapema 3
Itaquaquecetuba 3
Las Vegas 3
Totale 1.343
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 45
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 26
A case of renal melanoma metastasis: Description of clinico-pathological features 23
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 19
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 19
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 17
Management of AIDS-related Kaposi's sarcoma 17
An evolving role for immunotherapy in metastatic RCC 16
Instant messaging in cancer care 16
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 16
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 16
Development and validation of the PREVES-HOR Questionnaire: a patient-reported measure of hormone-therapy–related quality of life in prostate-cancer patients undergoing androgen-deprivation therapy 16
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 15
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 15
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 15
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 15
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 15
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 15
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 15
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 15
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 15
KIDNEY CANCER Overall survival is an unsuitable primary end point 15
Immunotherapy for the treatment of prostate cancer 14
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 14
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 14
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 14
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 14
Expression of HECA-452 in parapsoriasis and mycosis fungoides 14
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 14
Focus on localized laryngeal amyloidosis: Management of five cases 14
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 14
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 14
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 13
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 13
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 13
Involvement of growth factor receptors of the epidermal growth factor receptor (EGFR) family in prostate cancer development and in the progression to androgen- independence. 13
Expression of proto-oncogene c-kit in high risk prostate cancer 13
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 13
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy 13
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 13
New Agents for Prostate Cancer. 13
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 13
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 13
A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report 13
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 13
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 13
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer 13
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of literature 13
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer 13
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 12
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience 12
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 12
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 12
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 12
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 12
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 12
Numerical study of laminar confined impinging slot jets with nanofluids 12
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 12
New perspectives in the therapy of castration resistant prostate cancer 12
Optimal management of a patient with recurrent nasopharyngeal carcinoma 12
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 12
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 12
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 12
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 12
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 12
The role of immunotherapy in oncology 12
Complete response and fatigue improvement with the combined use of cyclophosphamide and quercetin in a patient with metastatic bladder cancer a case report 12
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 12
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 12
Combination therapy for metastatic renal cell carcinoma 12
Novel Chemotherapy-Sparing Approach for HER2-Low, ER-Positive Breast Cancer: Combining Trastuzumab Deruxtecan with Endocrine Therapy 12
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 12
Efficacy of Sunitinib Rechallenge in Kidney Cancer: Are mTOR Inhibitors Involved or Is It Only a Matter of Time? 12
Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 12
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 12
A comprehensive outlook on intracerebral therapy of malignant gliomas. 12
Activity of platinum-based chemotherapy in advanced prostate cancer patients with and without DNA repair gene aberrations: An International Collaborative Analysis 12
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 12
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial 11
Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks 11
LOOKING AT THE PROSTATES OF PATIENTS WITH BLADDER CANCER: A THOUGHTFUL EXERCISE 11
Long lasting response to second-line everolimus in kidney cancer. 11
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 11
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer 11
Optimal Management of Metastatic Castration-Resistant Prostate Cancer:Highlights from a European Expert Consensus Panel 11
TUMORI UROLOGICI: TUMORI DEL TESTICOLO, PROSTATA, RENE E VESCICA 11
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 11
The use of interferon in melanoma patients: a systematic review 11
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 11
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 11
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 11
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 11
Myrtucommulone Production by a Strain of Neofusicoccum australe Endophytic in Myrtle. 11
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 11
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 11
Efficacy of rituximab in gastric diffuse large B cell lymphoma patients 11
BAG3 protein delocalisation in prostate carcinoma 11
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 11
Words of Wisdom. Re: Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy 11
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 11
Totale 1.347
Categoria #
all - tutte 25.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/20261.125 266 27 355 434 43 0 0 0 0 0 0 0
Totale 3.290